Aldeyra Therapeutics, Inc. (ALDX)
5.05
-0.49
(-8.84%)
USD |
NASDAQ |
Dec 23, 16:00
5.06
+0.01
(+0.20%)
After-Hours: 07:05
Aldeyra Therapeutics SG&A Expense (TTM): 9.186M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| ADMA Biologics, Inc. | 96.37M |
| Exelixis, Inc. | 530.03M |
| Krystal Biotech, Inc. | 136.75M |